Skip to content

Biological Evaluation of Stereotactic Radiotherapy

Biological Evaluation of Stereotactic Radiotherapy

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800015499
Enrollment
Unknown
Registered
2018-04-20
Start date
2018-04-09
Completion date
Unknown
Last updated
2018-07-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver Cancer

Interventions

Sponsors

Wenzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Liver cancer patients: 1. Small liver cancer (= 5cm) or large liver cancer (5-10cm), Child-Pugh Classification (CPC-) A or B, clearly marked whether there is antiviral therapy; 2. First treatment by SBRT, BED 80Gy to 100Gy.

Exclusion criteria

Exclusion criteria: 1. The patients who can't complete radiotherapy; 2. The patients who are dropped out; 3. The patients who have received chemotherapy, targeted drug therapy and other comprehensive therapies that seriously affect blood biochemical indexes.

Design outcomes

Primary

MeasureTime frame
OS;PFS;Transcriptional indexes;

Countries

China

Contacts

Public ContactXiaodong Liu
liuxd2002@126.com+86 13179047972

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026